Exploring the possibility of a predictable precision therapy of COPD with inclusion of glycopyrronium responsiveness: A real-world experience

Background: The advent of glycopyrronium responsiveness has opened the prospect of selective responsiveness-based prescription of bronchodilators-β2-agonists or anti-muscarinic agents (AMA) for COPD. Such a concept needs ratification through clinical trials. Methods: Stable COPD patients [post-bronc...

Full description

Saved in:
Bibliographic Details
Main Authors: Parthasarathi Bhattacharyya, Shuvam Ghosh, Srijita Sen, Debkanya Dey, Sayoni Sengupta, Saayon Bej, Avishek Kar, Dipanjan Saha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Lung India
Subjects:
Online Access:https://journals.lww.com/10.4103/lungindia.lungindia_54_25
Tags: Add Tag
No Tags, Be the first to tag this record!